Strengthening Europe’s Health Security Through Innovation and Investment
Europe’s health resilience depends not only on preparedness, but also on the ability to develop, finance and bring innovative medical technologies to the point where they can be deployed when needed. A new investment agreement announced by the European Commission and the European Investment Bank illustrates this approach. On 11 September, the Commission and EIB […]
Scaling European Innovation: New EU Investment Push Targets High-Growth Companies
Scaling innovative companies requires more than early-stage funding. As European deep-tech and biotechnology companies move towards larger financing rounds and international markets, access to substantial growth capital remains an important part of the innovation ecosystem. A new group of European companies has now been selected for potential investment through the European Innovation Council’s STEP Scale Up […]
Europe Strengthens Its Bioeconomy Strategy: From Innovation to Scale
Europe is taking further steps to strengthen its bioeconomy and address one of the persistent challenges facing innovative companies: moving from research and demonstration to commercial scale. On 10 June, the European Commission launched three complementary initiatives to support implementation of the EU Bioeconomy Strategy: the Bio-based Europe Alliance (BEA), the Bioeconomy Investment Deployment Group (BIDG) and a […]
Free CPD Courses for Europe’s Life Sciences Workforce
Upskill for the Future of Health Innovation with BRIGHTskills As a proud partner of the BRIGHTskills project, CEBR is pleased to share a valuable opportunity for professionals across Europe’s life sciences, digital health and medical technologies sectors. BRIGHTskills offers a range of Continuous Professional Development (CPD) courses designed to help professionals develop the skills most […]
The Council of European BioRegions Announces New Board Leadership for 2026 – 2027
Uppsala, May 20, 2026 – The Council of European BioRegions (CEBR) is pleased to announce the appointment of its new Board leadership for the 2026-2027 mandate, following the elections held during the CEBR Annual Meeting in Sweden, hosted by STUNS Life Science and Stockholm Science City. The new Board leadership for the 2026-2027 mandate is composed […]
BioEquity Europe 2026 in Prague: Central Europe Steps Further into the Biotech Spotlight
In the first week of May, Prague hosted BioEquity Europe 2026, Europe’s leading conference focused on biotech investment and life science innovation. It was the first time in the event’s 26-year history that the conference took place in Central and Eastern Europe — a sign of how much the region’s biotech ecosystem has evolved in […]
CEBR Member bioPmed Strengthens Life Sciences Collaboration Between Piedmont and Canada
As part of its commitment to fostering international collaboration and strengthening global innovation networks, CEBR member bioPmed participated in an institutional mission to Canada together with Bioindustry Park Silvano Fumero and key regional stakeholders from Piedmont, Italy. Bioindustry Park Silvano Fumero and bioPmed – Piemonte Healthcare Cluster took part, representing the research and innovation system in the health […]
Celebrating 10 Years of EIT Health Catapult: a milestone edition shaping the future of European Health Innovation
The 10th edition of the EIT Health Catapult programme marks a significant milestone for one of Europe’s most established initiatives supporting early-stage Life Sciences and HealthTech startups. Following the application deadline at the end of April, a diverse cohort of high-potential startups from across Europe is now undergoing evaluation by an international panel of investors, […]
CEBR members contribute to joint call for a strong EU Biotech Act II on biomanufacturing
The Council of European Bioregions highlights the engagement of its members in a newly released joint position paper calling for an ambitious EU Biotech Act II focused on biomanufacturing. The initiative, led by EuropaBio and supported by 40+ European, national and regional organisations, underscores the growing momentum around Europe’s industrial bioeconomy agenda. The position paper […]
EIT Health Think Tank publishes Biotech Act report, featuring CEBR’s contribution and POLITICO Europe interview
Following the publication of the first part of the European Biotech Act, the EIT Health Think Tank has convened leading voices from across the continent to assess how Europe can strengthen its biotechnology innovation pathways. Among these experts is Montserrat Daban, President of the Board at the Council of European BioRegions (CEBR), who contributed to the Think […]
